It is worth noting that, in that study, it is suggested that missense variants in RECQL1 might show a marginal association with BC risk (OR, 1.12; p = 0.047; 95% CI, 1.00–1.26); however, given that that study, like ours, lacks a functional characterization of the missense variants, we do not believe that these results are valuable. This evidence concerns the gene RECQL and breast cancer.